FFAR2 and intestinal disorder: Propionate and acetate are additional substrates for the TCA cycle and ameliorate metabolic and intestinal diseases by activating intestinal gluconeogenesis (like microbiome-derived succinate117)118 and by enhancing innate immune responses via free fatty acid receptor 2 (FFAR2)-signaling119.